DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,054 filers reported holding DANAHER CORPORATION in Q4 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $286,823 | +4.0% | 1,156 | +0.6% | 0.06% | +13.5% |
| Q2 2023 | $275,678 | -6.1% | 1,149 | -1.4% | 0.05% | -13.3% |
| Q1 2023 | $293,675 | -6.2% | 1,165 | -1.3% | 0.06% | +42.9% |
| Q4 2022 | $313,184 | +5.1% | 1,180 | +2.1% | 0.04% | -42.5% |
| Q3 2022 | $298,000 | +0.3% | 1,156 | -1.2% | 0.07% | +21.7% |
| Q2 2022 | $297,000 | -29.1% | 1,170 | -18.0% | 0.06% | -20.0% |
| Q1 2022 | $419,000 | -26.1% | 1,427 | -17.2% | 0.08% | -20.2% |
| Q4 2021 | $567,000 | +12.1% | 1,724 | +3.7% | 0.09% | +4.4% |
| Q3 2021 | $506,000 | +28.4% | 1,662 | +13.1% | 0.09% | +25.0% |
| Q2 2021 | $394,000 | +66.2% | 1,469 | +39.5% | 0.07% | +33.3% |
| Q1 2021 | $237,000 | +6.8% | 1,053 | +5.4% | 0.05% | -3.6% |
| Q4 2020 | $222,000 | +39.6% | 999 | +35.5% | 0.06% | +7.7% |
| Q3 2020 | $159,000 | +35.9% | 737 | +11.3% | 0.05% | +15.6% |
| Q2 2020 | $117,000 | +46.2% | 662 | +13.9% | 0.04% | +21.6% |
| Q1 2020 | $80,000 | +116.2% | 581 | +138.1% | 0.04% | +164.3% |
| Q4 2019 | $37,000 | +184.6% | 244 | +180.5% | 0.01% | +133.3% |
| Q3 2019 | $13,000 | -13.3% | 87 | -14.7% | 0.01% | 0.0% |
| Q2 2019 | $15,000 | -6.2% | 102 | -15.0% | 0.01% | -25.0% |
| Q1 2019 | $16,000 | +100.0% | 120 | +53.8% | 0.01% | +60.0% |
| Q4 2018 | $8,000 | 0.0% | 78 | +5.4% | 0.01% | 0.0% |
| Q3 2018 | $8,000 | +33.3% | 74 | +23.3% | 0.01% | -16.7% |
| Q2 2018 | $6,000 | 0.0% | 60 | -10.4% | 0.01% | +50.0% |
| Q1 2018 | $6,000 | -14.3% | 67 | 0.0% | 0.00% | -20.0% |
| Q4 2017 | $7,000 | +133.3% | 67 | +97.1% | 0.01% | +66.7% |
| Q3 2017 | $3,000 | -70.0% | 34 | -73.2% | 0.00% | -70.0% |
| Q2 2017 | $10,000 | +400.0% | 127 | +370.4% | 0.01% | +400.0% |
| Q1 2017 | $2,000 | 0.0% | 27 | 0.0% | 0.00% | -33.3% |
| Q4 2016 | $2,000 | – | 27 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |